Logo image of ICHR

ICHOR HOLDINGS LTD (ICHR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ICHR - KYG4740B1059 - Common Stock

28.43 USD
+2.3 (+8.8%)
Last: 1/14/2026, 2:44:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ICHR. ICHR was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. ICHR scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ICHR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year ICHR was profitable.
  • In the past year ICHR had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ICHR reported negative net income in multiple years.
  • In the past 5 years ICHR always reported a positive cash flow from operatings.
ICHR Yearly Net Income VS EBIT VS OCF VS FCFICHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

1.2 Ratios

  • With a Return On Assets value of -4.22%, ICHR is not doing good in the industry: 63.72% of the companies in the same industry are doing better.
  • ICHR has a Return On Equity of -6.03%. This is in the lower half of the industry: ICHR underperforms 62.83% of its industry peers.
Industry RankSector Rank
ROA -4.22%
ROE -6.03%
ROIC N/A
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ICHR Yearly ROA, ROE, ROICICHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

  • With a Gross Margin value of 9.80%, ICHR is not doing good in the industry: 85.84% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of ICHR has declined.
  • The Profit Margin and Operating Margin are not available for ICHR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
ICHR Yearly Profit, Operating, Gross MarginsICHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

4

2. Health

2.1 Basic Checks

  • ICHR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ICHR has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ICHR has more shares outstanding
  • ICHR has a better debt/assets ratio than last year.
ICHR Yearly Shares OutstandingICHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
ICHR Yearly Total Debt VS Total AssetsICHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • ICHR has an Altman-Z score of 3.32. This indicates that ICHR is financially healthy and has little risk of bankruptcy at the moment.
  • ICHR has a Altman-Z score (3.32) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.17 indicates that ICHR is not too dependend on debt financing.
  • ICHR's Debt to Equity ratio of 0.17 is in line compared to the rest of the industry. ICHR outperforms 50.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 3.32
ROIC/WACCN/A
WACC10.66%
ICHR Yearly LT Debt VS Equity VS FCFICHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

  • ICHR has a Current Ratio of 3.08. This indicates that ICHR is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 3.08, ICHR is in line with its industry, outperforming 53.98% of the companies in the same industry.
  • A Quick Ratio of 1.33 indicates that ICHR should not have too much problems paying its short term obligations.
  • With a Quick ratio value of 1.33, ICHR is not doing good in the industry: 77.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 3.08
Quick Ratio 1.33
ICHR Yearly Current Assets VS Current LiabilitesICHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

  • ICHR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1400.00%, which is quite impressive.
  • ICHR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -33.82% yearly.
  • The Revenue has grown by 16.86% in the past year. This is quite good.
  • ICHR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.46% yearly.
EPS 1Y (TTM)1400%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%-41.67%
Revenue 1Y (TTM)16.86%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%13.34%

3.2 Future

  • Based on estimates for the next years, ICHR will show a very strong growth in Earnings Per Share. The EPS will grow by 73.41% on average per year.
  • Based on estimates for the next years, ICHR will show a quite strong growth in Revenue. The Revenue will grow by 10.33% on average per year.
EPS Next Y7.01%
EPS Next 2Y115.47%
EPS Next 3Y112.98%
EPS Next 5Y73.41%
Revenue Next Year11.33%
Revenue Next 2Y8.4%
Revenue Next 3Y8.88%
Revenue Next 5Y10.33%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ICHR Yearly Revenue VS EstimatesICHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B
ICHR Yearly EPS VS EstimatesICHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 94.77, ICHR can be considered very expensive at the moment.
  • ICHR's Price/Earnings ratio is in line with the industry average.
  • ICHR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.30.
  • The Price/Forward Earnings ratio is 38.27, which means the current valuation is very expensive for ICHR.
  • ICHR's Price/Forward Earnings ratio is in line with the industry average.
  • ICHR is valuated expensively when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 94.77
Fwd PE 38.27
ICHR Price Earnings VS Forward Price EarningsICHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • ICHR's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 195.72
ICHR Per share dataICHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as ICHR's earnings are expected to grow with 112.97% in the coming years.
PEG (NY)13.52
PEG (5Y)N/A
EPS Next 2Y115.47%
EPS Next 3Y112.98%

0

5. Dividend

5.1 Amount

  • ICHR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ICHOR HOLDINGS LTD

NASDAQ:ICHR (1/14/2026, 2:44:01 PM)

28.43

+2.3 (+8.8%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)11-03
Earnings (Next)02-02
Inst Owners98.06%
Inst Owner Change0.07%
Ins Owners2.11%
Ins Owner Change21.13%
Market Cap977.42M
Revenue(TTM)957.34M
Net Income(TTM)-40.76M
Analysts78.46
Price Target24.31 (-14.49%)
Short Float %9.56%
Short Ratio4.11
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.69%
Min EPS beat(2)-79.27%
Max EPS beat(2)-42.12%
EPS beat(4)0
Avg EPS beat(4)-46.48%
Min EPS beat(4)-79.27%
Max EPS beat(4)-9.51%
EPS beat(8)2
Avg EPS beat(8)-601.07%
EPS beat(12)4
Avg EPS beat(12)-374.76%
EPS beat(16)6
Avg EPS beat(16)-280.24%
Revenue beat(2)1
Avg Revenue beat(2)0.11%
Min Revenue beat(2)-0.23%
Max Revenue beat(2)0.45%
Revenue beat(4)1
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-2.16%
Max Revenue beat(4)0.45%
Revenue beat(8)4
Avg Revenue beat(8)-0.16%
Revenue beat(12)6
Avg Revenue beat(12)-0.3%
Revenue beat(16)8
Avg Revenue beat(16)-0.27%
PT rev (1m)0%
PT rev (3m)-1.38%
EPS NQ rev (1m)-80.7%
EPS NQ rev (3m)-143.8%
EPS NY rev (1m)-16.37%
EPS NY rev (3m)-58.38%
Revenue NQ rev (1m)-0.9%
Revenue NQ rev (3m)-5.87%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-1.01%
Valuation
Industry RankSector Rank
PE 94.77
Fwd PE 38.27
P/S 1.02
P/FCF N/A
P/OCF 53.62
P/B 1.45
P/tB 3.28
EV/EBITDA 195.72
EPS(TTM)0.3
EY1.06%
EPS(NY)0.74
Fwd EY2.61%
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)0.53
OCFY1.86%
SpS27.85
BVpS19.67
TBVpS8.68
PEG (NY)13.52
PEG (5Y)N/A
Graham Number11.52
Profitability
Industry RankSector Rank
ROA -4.22%
ROE -6.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.8%
FCFM N/A
ROA(3y)0.02%
ROA(5y)2.26%
ROE(3y)0.6%
ROE(5y)4.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.35%
GM growth 5Y-2.65%
F-Score4
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 24.68
Cap/Depr 118.71%
Cap/Sales 3.9%
Interest Coverage N/A
Cash Conversion 383.91%
Profit Quality N/A
Current Ratio 3.08
Quick Ratio 1.33
Altman-Z 3.32
F-Score4
WACC10.66%
ROIC/WACCN/A
Cap/Depr(3y)62.01%
Cap/Depr(5y)61.74%
Cap/Sales(3y)2.1%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1400%
EPS 3Y-63.79%
EPS 5Y-33.82%
EPS Q2Q%-41.67%
EPS Next Y7.01%
EPS Next 2Y115.47%
EPS Next 3Y112.98%
EPS Next 5Y73.41%
Revenue 1Y (TTM)16.86%
Revenue growth 3Y-8.18%
Revenue growth 5Y6.46%
Sales Q2Q%13.34%
Revenue Next Year11.33%
Revenue Next 2Y8.4%
Revenue Next 3Y8.88%
Revenue Next 5Y10.33%
EBIT growth 1Y-86.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year211.09%
EBIT Next 3Y69.58%
EBIT Next 5Y50.15%
FCF growth 1Y-149.43%
FCF growth 3YN/A
FCF growth 5Y-22.51%
OCF growth 1Y-69.02%
OCF growth 3Y22.22%
OCF growth 5Y-13.37%

ICHOR HOLDINGS LTD / ICHR FAQ

What is the ChartMill fundamental rating of ICHOR HOLDINGS LTD (ICHR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICHR.


Can you provide the valuation status for ICHOR HOLDINGS LTD?

ChartMill assigns a valuation rating of 2 / 10 to ICHOR HOLDINGS LTD (ICHR). This can be considered as Overvalued.


How profitable is ICHOR HOLDINGS LTD (ICHR) stock?

ICHOR HOLDINGS LTD (ICHR) has a profitability rating of 2 / 10.


What is the financial health of ICHOR HOLDINGS LTD (ICHR) stock?

The financial health rating of ICHOR HOLDINGS LTD (ICHR) is 4 / 10.